OraSure Technologies | OSUR - 流动负债



金融业
股票价格
USD
资产
USD 360.55M
现金及等价物
USD 160.58M
销售成本
USD 15.43M
流动资产
USD 222.94M
流动负债
USD 25.12M
债务
USD 782K
股息收益率
0
EBIT
USD -13.59M
EBITDA
USD -17.7M
员工
638
EPS每股收益
USD -0.18
股本和储备
USD 317.78M
销售毛利
USD 11.34M
债务利息支出
1.67M
贷款资金
USD 100K
市值
USD 282.3M
净收入
USD -19.29M
营业费用
USD 40.35M
营业利润
USD -13.59M
普通股股本
USD 70.39M
PE价格收益
24.42
税前利润
USD -18.43M
销售收入
USD 26.76M
销售和管理费用
USD 13.21M
股票
USD 30.07M
贸易债权人
USD 8.4M
应收帐款人
USD 22.2M


流动负债 更改 日
Agilent USD 2.27B 35M 2026-03
AngioDynamics USD 71.96M 3.68M 2025-09
Becton, Dickinson and Co. USD 9.4B 897M 2026-06
Bio Techne USD 153.28M 12.85M 2026-03
Bio-Rad Laboratories USD 961.3M 44.3M 2026-06
Bruker USD 1.2B 150.4M 2026-06
Cerus USD 100.8M 12.37M 2025-12
Charles River Laboratories USD 1.13B 41.04M 2026-06
Danaher USD 8.1B 645M 2026-06
Dentsply International USD 1.18B 22M 2026-06
Dexcom USD 2.36B 133.9M 2026-06
Illumina USD 1.58B 12M 2026-06
Integra LifeSciences USD 330.88M 15.96M 2026-06
Intuitive Surgical USD 2.58B 65.1M 2026-06
IQVIA Holdings USD 8.82B 486M 2026-06
Mesa Laboratories USD 54.4M 6.1M 2025-12
Mettler Toledo International USD 1.2B 92.14M 2026-06
Myriad Genetics USD 130.7M 500K 2026-06
OraSure Technologies USD 25.12M 18.96M 2026-06
Quidel USD 993.4M 31M 2026-06
Repligen USD 132.66M 6.45M 2026-06
Revvity USD 1.28B 37.71M 2026-06
STAAR Surgical USD 73.39M 12.4M 2026-06
Thermo Fisher Scientific USD 15.07B 448M 2026-06
Trinity Biotech USD 141.21M 106.72M 2025-12
Waters USD 2.27B 1.03B 2026-03